APA (7th ed.) Citation

Ilieva, K., Landgraf, K., Boxhammer, R., Steidl, S., & Flesher, D. WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES. Elsevier.

Chicago Style (17th ed.) Citation

Ilieva, Kristina, Karin Landgraf, Rainer Boxhammer, Stefan Steidl, and Donna Flesher. WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES. Elsevier.

MLA (9th ed.) Citation

Ilieva, Kristina, et al. WCN25-744 FELZARTAMAB SELECTIVELY AND POTENTLY TARGETS CD38+ ANTIBODY SECRETING CELLS FROM PATIENTS WITH IMMUNE-MEDIATED KIDNEY DISEASES. Elsevier.